TetO-dCas9-D3A Citations (2)

Originally described in: Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation.
McDonald JI, Celik H, Rois LE, Fishberger G, Fowler T, Rees R, Kramer A, Martens A, Edwards JR, Challen GA Biol Open. 2016 May 11. pii: bio.019067. doi: 10.1242/bio.019067. PubMed Journal

---

Articles Citing TetO-dCas9-D3A

Articles
A methylation functional detection hepatic cell system validates correlation between DNA methylation and drug-induced liver injury. Wei Y, Huai C, Zhou C, Gao Y, Chen L, Zhou W, Wei M, Qin S. Pharmacogenomics J. 2020 Feb 7. pii: 10.1038/s41397-020-0160-7. doi: 10.1038/s41397-020-0160-7. PubMed
Discovery of potential small molecule inhibitors against beta-hCG: an in silico study with in vitro validation. Ittycheria SS, Sivakumar KC, Patra D, Ramachandran B, Neetha RL, Warrier AV, Aiswariya MA, Kaviya S, Suman P, Narayanaswamy N, Srinivas P. RSC Adv. 2025 Jun 10;15(25):19561-19580. doi: 10.1039/d4ra08663e. eCollection 2025 Jun 10. PubMed

If you have published an article using this material, please email us at to have your article added to this page.